Company profile: Third Pole
1.1 - Company Overview
Company description
- Provider of electric nitric oxide generation and delivery solutions for hospital, ambulatory, and home use. Products include eNOfit, a portable inhaled nitric oxide device for on-the-go treatment of severe COPD and ILD; eNOcare, an FDA-designated breakthrough hospital device for critical life-sustaining therapies; and on-demand iNO generation technology from air for bedside and portable therapy.
Products and services
- Portable Nitric Oxide Generation Technology: Produces inhaled nitric oxide on-demand from air, enabling bedside and portable therapy across hospital, ambulatory, and home applications
- ENOcare: A hospital-grade device that delivers inhaled nitric oxide for life-sustaining therapies, designated a 'breakthrough' by the FDA for inpatient care
- ENOfit: An ambulatory-grade portable device delivering inhaled nitric oxide for on-the-go treatment of severe COPD and ILD, supporting ambulatory therapy.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Third Pole
InaVein
HQ: United States
Website
- Description: Provider of innovative products to treat the full spectrum of vein disorders. Founded in 2007, InaVein develops and commercializes technologies including the TRIVEX System, which uses direct visualization to completely remove varicose veins in a shorter period of time compared to conventional phlebectomy procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InaVein company profile →
Millipede Medical
HQ: United States
Website
- Description: Provider of a percutaneous, catheter-based solution for mitral valve repair and treatment of mitral and tricuspid regurgitation, restoring health and expanding options for physicians and patients globally.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Millipede Medical company profile →
Boston Heart Diagnostics
HQ: United States
Website
- Description: Provider of cardiovascular disease management solutions, combining proprietary lipid testing, advanced diagnostics, therapy guidelines, and patient support. Offerings include CVMap, Polygenic Risk Map, LipoMap NMR lipid panel, dried blood spot testing with 40+ assays, advanced lipid tests for risk stratification and chronic care, and a tailored lifestyle program for long-term health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Boston Heart Diagnostics company profile →
PLC Medical Systems
HQ: United States
Website
- Description: Provider of health care solutions as a Health Care company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PLC Medical Systems company profile →
XO1
HQ: United Kingdom
Website
- Description: Provider of virtual biotechnology development focused on ichorcumab, operating without offices or laboratories by engaging high-quality contract research and development specialists in Europe and the US, managed by a small team of experienced drug developers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full XO1 company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Third Pole
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Third Pole
2.2 - Growth funds investing in similar companies to Third Pole
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Third Pole
4.2 - Public trading comparable groups for Third Pole
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →